메뉴 건너뛰기




Volumn 32, Issue 20, 2014, Pages 2359-2363

Re-examination of immune response and estimation of anti-Vi IgG protective threshold against typhoid fever-based on the efficacy trial of Vi conjugate in young children

Author keywords

Vi antibody protective threshold against typhoid fever Vi conjugate efficacy trial

Indexed keywords

IMMUNOGLOBULIN G; PLACEBO; TYPHOID VACCINE;

EID: 84897514742     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2014.02.050     Document Type: Article
Times cited : (25)

References (24)
  • 1
    • 73649135423 scopus 로고    scopus 로고
    • Global trends in typhoid and paratyphoid fever
    • Crump J.A., Mintz E.D. Global trends in typhoid and paratyphoid fever. Clin Infect Dis 2010, 50:241-246.
    • (2010) Clin Infect Dis , vol.50 , pp. 241-246
    • Crump, J.A.1    Mintz, E.D.2
  • 2
    • 42049095893 scopus 로고    scopus 로고
    • A study of typhoid fever in five Asian countries: disease burden and implications for controls DOMI typhoid study group
    • Ochai R.L., Acosta C.J., Danovaro-Holiday M.C., Baiqing D., Bhattacharya S.K., Agtini M.D., et al. A study of typhoid fever in five Asian countries: disease burden and implications for controls DOMI typhoid study group. Bull World Health Organ 2008, 86(April (4)):260-268.
    • (2008) Bull World Health Organ , vol.86 , Issue.APRIL 4 , pp. 260-268
    • Ochai, R.L.1    Acosta, C.J.2    Danovaro-Holiday, M.C.3    Baiqing, D.4    Bhattacharya, S.K.5    Agtini, M.D.6
  • 3
    • 84897518288 scopus 로고
    • Requirements for Vi polysaccharide typhoid vaccine. World Health Organization Technical Report Series
    • Requirements for Vi polysaccharide typhoid vaccine. World Health Organization Technical Report Series. 1994; No. 840.
    • (1994) , pp. 840
  • 4
    • 0023243082 scopus 로고
    • Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: a preliminary report one year after immunization
    • Acharya I.L., Lowe C.U., Thapa R., Gurubacharya V.L., Shrestha M.B., Bryla D.A., et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi: a preliminary report one year after immunization. N Engl J Med 1987, 317:1101-1104.
    • (1987) N Engl J Med , vol.317 , pp. 1101-1104
    • Acharya, I.L.1    Lowe, C.U.2    Thapa, R.3    Gurubacharya, V.L.4    Shrestha, M.B.5    Bryla, D.A.6
  • 5
    • 0023633872 scopus 로고
    • Protective activity of Vi capsular polysaccharide vaccine against typhoid fever
    • Vaccine Advisory Committee
    • Klugman K.P., Gilbertson I.T., Koornhof H.J., Robbins J.B., Schneerson R., Schultz D., et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet 1987, II:1165-1169. Vaccine Advisory Committee.
    • (1987) Lancet , vol.2 , pp. 1165-1169
    • Klugman, K.P.1    Gilbertson, I.T.2    Koornhof, H.J.3    Robbins, J.B.4    Schneerson, R.5    Schultz, D.6
  • 6
    • 0035953692 scopus 로고    scopus 로고
    • The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children
    • Lin F.-Y., Ho V.A., Khiem H.B., Trach D.D., Bay P.V., Thanh T.C., et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children. N Engl J Med 2001, 344:1263-1269.
    • (2001) N Engl J Med , vol.344 , pp. 1263-1269
    • Lin, F.-Y.1    Ho, V.A.2    Khiem, H.B.3    Trach, D.D.4    Bay, P.V.5    Thanh, T.C.6
  • 7
    • 0141542621 scopus 로고    scopus 로고
    • Persistent efficacy of Vi conjugates against typhoid fever in young children
    • Lanh M.N., Bay P.V., Ho V.A., Thanh T.C., Lin F.Y., Bryla D.A., et al. Persistent efficacy of Vi conjugates against typhoid fever in young children. N Engl J Med 2003, 349:1390-1391.
    • (2003) N Engl J Med , vol.349 , pp. 1390-1391
    • Lanh, M.N.1    Bay, P.V.2    Ho, V.A.3    Thanh, T.C.4    Lin, F.Y.5    Bryla, D.A.6
  • 8
    • 84887390836 scopus 로고    scopus 로고
    • Development of Vi conjugate, a new generation of typhoid vaccine
    • Szu S.C. Development of Vi conjugate, a new generation of typhoid vaccine. Exp Rev Vaccine 2013, 12(11):1275-1286.
    • (2013) Exp Rev Vaccine , vol.12 , Issue.11 , pp. 1275-1286
    • Szu, S.C.1
  • 9
    • 80051668428 scopus 로고    scopus 로고
    • Coalition against Typhoid (CaT): a new, global initiative to advance typhoid vaccination
    • Nelson C.B., de Quadros C. Coalition against Typhoid (CaT): a new, global initiative to advance typhoid vaccination. Vaccine 2011, 29:6443.
    • (2011) Vaccine , vol.29 , pp. 6443
    • Nelson, C.B.1    de Quadros, C.2
  • 10
    • 84883600598 scopus 로고    scopus 로고
    • Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012
    • Jones C., Lee C.K., Ahn C., Shin J., Knezevic I. Working Group on quality, safety and efficacy of typhoid Vi capsular polysaccharide conjugate, vaccines, Jeju, Republic of Korea, 5-7 September 2012. Vaccine 2013, 31(41):4466-4469.
    • (2013) Vaccine , vol.31 , Issue.41 , pp. 4466-4469
    • Jones, C.1    Lee, C.K.2    Ahn, C.3    Shin, J.4    Knezevic, I.5
  • 11
    • 0026339060 scopus 로고
    • Vaccine efficacy determination
    • [discussion 222-4]
    • Broome C.V. Vaccine efficacy determination. NIPH Ann 1991, 14:219-221. [discussion 222-4].
    • (1991) NIPH Ann , vol.14 , pp. 219-221
    • Broome, C.V.1
  • 12
    • 0041324979 scopus 로고    scopus 로고
    • Measurement and interpretation of pneumococcal IgG levels for clinical management
    • Balmer P., North J., Baxter D., Stanford E., Melegaro A., Kaczmarski E.B., et al. Measurement and interpretation of pneumococcal IgG levels for clinical management. Clin Exp Immunol 2003, 133(3):364-369.
    • (2003) Clin Exp Immunol , vol.133 , Issue.3 , pp. 364-369
    • Balmer, P.1    North, J.2    Baxter, D.3    Stanford, E.4    Melegaro, A.5    Kaczmarski, E.B.6
  • 13
    • 2542584255 scopus 로고
    • Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever
    • Tacket C.O., Levine M.M., Robbins J.B. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever. Vaccine 1988, 6(4):307-308.
    • (1988) Vaccine , vol.6 , Issue.4 , pp. 307-308
    • Tacket, C.O.1    Levine, M.M.2    Robbins, J.B.3
  • 14
    • 84875237913 scopus 로고    scopus 로고
    • A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned
    • Szu S.C., Hunt S., Xie G.L., Robbins J.B., Schneerson R., Zhao Z.Q., et al. A human IgG anti-Vi reference for Salmonella typhi with weight-based antibody units assigned. Vaccine 2013, 31(15):1970-1974.
    • (2013) Vaccine , vol.31 , Issue.15 , pp. 1970-1974
    • Szu, S.C.1    Hunt, S.2    Xie, G.L.3    Robbins, J.B.4    Schneerson, R.5    Zhao, Z.Q.6
  • 15
    • 0032889959 scopus 로고    scopus 로고
    • Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization
    • Keddy K.H., Klugman K.P., Hansford C.F., Blondeau C., Bouveret le Cam N.N. Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization. Vaccine 1999, 17(2):110-113.
    • (1999) Vaccine , vol.17 , Issue.2 , pp. 110-113
    • Keddy, K.H.1    Klugman, K.P.2    Hansford, C.F.3    Blondeau, C.4    Bouveret le Cam, N.N.5
  • 16
    • 0029881198 scopus 로고    scopus 로고
    • Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization
    • Klugman K.P., Koornhof H.J., Robbins J.B., Le Cam N.N. Immunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization. Vaccine 1996, 14:435-438.
    • (1996) Vaccine , vol.14 , pp. 435-438
    • Klugman, K.P.1    Koornhof, H.J.2    Robbins, J.B.3    Le Cam, N.N.4
  • 17
    • 0037449054 scopus 로고    scopus 로고
    • Correlates of immunity for pneumococcal conjugate vaccines
    • [Review]
    • Lee L.H., Frasch C.E., Falk L.A., Klein D.L., Deal C.D. Correlates of immunity for pneumococcal conjugate vaccines. Vaccine 2003, 16(21):2190-2196. [Review].
    • (2003) Vaccine , vol.16 , Issue.21 , pp. 2190-2196
    • Lee, L.H.1    Frasch, C.E.2    Falk, L.A.3    Klein, D.L.4    Deal, C.D.5
  • 18
    • 0031841825 scopus 로고    scopus 로고
    • Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine
    • Sorensen R.U., Leiva L.E., Giangrosso P.A., Butler B., Javier F.C., Sacerdote D.M., et al. Response to a heptavalent conjugate Streptococcus pneumoniae vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 1998, 17(8):685-691.
    • (1998) Pediatr Infect Dis J , vol.17 , Issue.8 , pp. 685-691
    • Sorensen, R.U.1    Leiva, L.E.2    Giangrosso, P.A.3    Butler, B.4    Javier, F.C.5    Sacerdote, D.M.6
  • 19
    • 0018663654 scopus 로고
    • Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization in infants and children
    • Gold R., Lepow M.L., Goldschneider I., Draper T.F., Gotshlich E.C. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization in infants and children. J Infect Dis 1979, 140:690-697.
    • (1979) J Infect Dis , vol.140 , pp. 690-697
    • Gold, R.1    Lepow, M.L.2    Goldschneider, I.3    Draper, T.F.4    Gotshlich, E.C.5
  • 20
    • 0021832508 scopus 로고
    • Comparative analysis of two rates
    • Miettinen O., Nurminen M. Comparative analysis of two rates. Stat Med 1985, 4(2):213-226.
    • (1985) Stat Med , vol.4 , Issue.2 , pp. 213-226
    • Miettinen, O.1    Nurminen, M.2
  • 21
    • 7044226171 scopus 로고    scopus 로고
    • Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children
    • Canh D.G., Lin F.Y., Thiem V.D., Trach D.D., Trong N.D., Mao N.D., et al. Effect of dosage on immunogenicity of a Vi conjugate vaccine injected twice into 2- to 5-year-old Vietnamese children. Infect Immun 2004, 72(11):6586-6588.
    • (2004) Infect Immun , vol.72 , Issue.11 , pp. 6586-6588
    • Canh, D.G.1    Lin, F.Y.2    Thiem, V.D.3    Trach, D.D.4    Trong, N.D.5    Mao, N.D.6
  • 22
    • 77954357410 scopus 로고    scopus 로고
    • Correlates of protection induced by vaccination
    • Plotkin S.A. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010, 17(7):1055-1065.
    • (2010) Clin Vaccine Immunol , vol.17 , Issue.7 , pp. 1055-1065
    • Plotkin, S.A.1
  • 23
    • 34247120588 scopus 로고    scopus 로고
    • Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies
    • Siber G.R., Chang I., Baker S., Fernsten P., O'Brien K.L., Santosham M., et al. Estimating the protective concentration of anti-pneumococcal capsular polysaccharide antibodies. Vaccine 2007, 25(19):3816-3826.
    • (2007) Vaccine , vol.25 , Issue.19 , pp. 3816-3826
    • Siber, G.R.1    Chang, I.2    Baker, S.3    Fernsten, P.4    O'Brien, K.L.5    Santosham, M.6
  • 24
    • 0017698226 scopus 로고
    • Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age
    • Peltola H., Mäkelä H., Käyhty H., Jousimies H., Herva E., Hällström K., et al. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 1977, 297(13):686-691.
    • (1977) N Engl J Med , vol.297 , Issue.13 , pp. 686-691
    • Peltola, H.1    Mäkelä, H.2    Käyhty, H.3    Jousimies, H.4    Herva, E.5    Hällström, K.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.